PedAM
Pediatric Disease Annotations & Medicines
| Disease | psoriasis |
| Phenotype | C0011847|diabetes |
| Sentences | 18 |
| PubMedID- 23772556 | For each study we collected the first author's last name, publication year, country of origin, study design, characteristics of participants (sample size, age and sex), the variables incorporated into the multivariable analyses, and the odds ratios (ors) of psoriasis associated with diabetes along with the corresponding 95% confidence intervals (cis). |
| PubMedID- 23441722 | The most prevalent comorbid conditions were hypertensive disease and diabetes among patients with psoriasis, psoriatic arthritis, or both. |
| PubMedID- 24506139 | Background: a few case reports suggest that incretin-based therapies could improve psoriasis in patients with type 2 diabetes, the mechanism(s) of which remain unclear. |
| PubMedID- 22710320 | Objective: to assess the risk of incident diabetes mellitus (dm) in patients with psoriasis and to evaluate dm treatment patterns among patients with psoriasis and incident dm. |
| PubMedID- 23843781 | Previous studies have reported an increased prevalence of diabetes in patients with psoriasis [1, 5–17, 21]. |
| PubMedID- 25599394 | After controlling for major confounders, in the cross-sectional analysis psoriasis was significantly associated with type 2 diabetes (t2d, adjusted odds ratio (or)=2.36; 95% confidence interval ci=1.26-4.41) and myocardial infarction (mi, or=2.26; 95% ci=1.03-4.96). |
| PubMedID- 23407990 | Five of these studies assessed the incidence of diabetes in patients with psoriasis and were analyzed separately. |
| PubMedID- 23432425 | Rapid improvement of psoriasis in diabetes subsequent to glucose lowering. |
| PubMedID- 21993559 | The prevalence of co-morbidities such as insulin resistance, metabolic syndrome and type 2 diabetes (t2d) associated with psoriasis has gained interest in recent years, while most were cross-sectional (cohen et al., 2008; driessen et al., 2009; henseler and christophers, 1995; kimball et al., 2008; lindegard, 1986; love et al., 2011; neimann et al., 2006; pearce et al., 2005) or case-control studies (brauchli et al., 2008; gerdes et al., 2008; gisondi et al., 2007; naldi et al., 2008; shapiro et al., 2007; sommer et al., 2006; vena et al., 2010; wu et al., 2008), and inflammation seems to be an underlying mechanism (davidovici et al., 2010; hu et al., 2004; pradhan et al., 2001). |
| PubMedID- 21395695 | Also, psoriasis coincides with lipid disturbances, diabetes and diseases of cardiovascular system. |
| PubMedID- 24835483 | Our analysis of nhanes data indicated that psoriasis was not associated with diabetes but was positively associated with hypertension, overweight/obesity and waist circumference. |
| PubMedID- 25713604 | Thus, it seems that the risk of diabetes in psoriasis is linked to insulin resistance [18]. |
| PubMedID- 25412565 | Other exclusion criteria included uvb therapy within the 2 weeks before baseline, diabetes mellitus, current diagnosis of unstable forms of psoriasis, skin infection, infestations or atrophy of the scalp, and severe renal or hepatic disorders. |
| PubMedID- 21619651 | diabetes, thyroiditis of hashimoto, psoriasis), as well as with extra-intestinal complications such as neurologic and psychiatric disturbances, which may either follow or precede symptoms and diagnosis of the celiac disease [4-6]. |
| PubMedID- 26357664 | [2] reported that antidepressant medication was increased in diabetes patients with psoriasis compared to the reference population without psoriasis. |
| PubMedID- 23134418 | Conclusions: psoriasis is strongly associated with hypertension, diabetes mellitus and obesity. |
| PubMedID- 26366154 | Confirm the coexistence of diabetes in patients with severe psoriasis in 7.1% and with mild psoriasis in 4.4% compared to the control group (3.3%) [36]. |
| PubMedID- 22121269 | [8] there is a paucity of literature highlighting the association of psoriasis with diabetes, dyslipidemias, and cardiovascular disorders in indian populations. |
Page: 1